IBDEI04X ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6278,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOUS
 ;;^UTILITY(U,$J,358.3,6278,2)
 ;;=^24388
 ;;^UTILITY(U,$J,358.3,6279,0)
 ;;=582.2^^37^444^11
 ;;^UTILITY(U,$J,358.3,6279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6279,1,3,0)
 ;;=3^582.2
 ;;^UTILITY(U,$J,358.3,6279,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOPROLIF
 ;;^UTILITY(U,$J,358.3,6279,2)
 ;;=^24386
 ;;^UTILITY(U,$J,358.3,6280,0)
 ;;=582.4^^37^444^15
 ;;^UTILITY(U,$J,358.3,6280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6280,1,3,0)
 ;;=3^582.4
 ;;^UTILITY(U,$J,358.3,6280,1,4,0)
 ;;=4^NEPHRITIS,CHR RAPID PROGR
 ;;^UTILITY(U,$J,358.3,6280,2)
 ;;=^270348
 ;;^UTILITY(U,$J,358.3,6281,0)
 ;;=582.81^^37^444^10
 ;;^UTILITY(U,$J,358.3,6281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6281,1,3,0)
 ;;=3^582.81
 ;;^UTILITY(U,$J,358.3,6281,1,4,0)
 ;;=4^NEPHRITIS,CHR IN OTH DIS
 ;;^UTILITY(U,$J,358.3,6281,2)
 ;;=^270350
 ;;^UTILITY(U,$J,358.3,6282,0)
 ;;=582.9^^37^444^13
 ;;^UTILITY(U,$J,358.3,6282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6282,1,3,0)
 ;;=3^582.9
 ;;^UTILITY(U,$J,358.3,6282,1,4,0)
 ;;=4^NEPHRITIS,CHR NOS
 ;;^UTILITY(U,$J,358.3,6282,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,6283,0)
 ;;=583.81^^37^444^5
 ;;^UTILITY(U,$J,358.3,6283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6283,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,6283,1,4,0)
 ;;=4^NEPHRITIS IN OTH DIS
 ;;^UTILITY(U,$J,358.3,6283,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,6284,0)
 ;;=583.81^^37^444^16
 ;;^UTILITY(U,$J,358.3,6284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6284,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,6284,1,4,0)
 ;;=4^SECONDARY GLOMERONEPHRITIS
 ;;^UTILITY(U,$J,358.3,6284,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,6285,0)
 ;;=583.9^^37^444^6
 ;;^UTILITY(U,$J,358.3,6285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6285,1,3,0)
 ;;=3^583.9
 ;;^UTILITY(U,$J,358.3,6285,1,4,0)
 ;;=4^NEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,6285,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,6286,0)
 ;;=710.0^^37^444^17
 ;;^UTILITY(U,$J,358.3,6286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6286,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,6286,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,6286,2)
 ;;=^72159^582.81
 ;;^UTILITY(U,$J,358.3,6287,0)
 ;;=582.89^^37^445^2
 ;;^UTILITY(U,$J,358.3,6287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6287,1,3,0)
 ;;=3^582.89
 ;;^UTILITY(U,$J,358.3,6287,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,CHR
 ;;^UTILITY(U,$J,358.3,6287,2)
 ;;=^270349
 ;;^UTILITY(U,$J,358.3,6288,0)
 ;;=580.89^^37^445^1
 ;;^UTILITY(U,$J,358.3,6288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6288,1,3,0)
 ;;=3^580.89
 ;;^UTILITY(U,$J,358.3,6288,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,AC
 ;;^UTILITY(U,$J,358.3,6288,2)
 ;;=^270340
 ;;^UTILITY(U,$J,358.3,6289,0)
 ;;=583.89^^37^445^3
 ;;^UTILITY(U,$J,358.3,6289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6289,1,3,0)
 ;;=3^583.89
 ;;^UTILITY(U,$J,358.3,6289,1,4,0)
 ;;=4^NEPHROPATHY,ANALGESIC
 ;;^UTILITY(U,$J,358.3,6289,2)
 ;;=^83443
 ;;^UTILITY(U,$J,358.3,6290,0)
 ;;=042.^^37^446^1
 ;;^UTILITY(U,$J,358.3,6290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6290,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,6290,1,4,0)
 ;;=4^AIDS
 ;;^UTILITY(U,$J,358.3,6290,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,6291,0)
 ;;=581.1^^37^446^2
 ;;^UTILITY(U,$J,358.3,6291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6291,1,3,0)
 ;;=3^581.1
 ;;^UTILITY(U,$J,358.3,6291,1,4,0)
 ;;=4^NEPHRITIS EPIMEMBRANOUS (FSGS)
 ;;^UTILITY(U,$J,358.3,6291,2)
 ;;=^270344
 ;;^UTILITY(U,$J,358.3,6292,0)
 ;;=581.2^^37^446^3
 ;;^UTILITY(U,$J,358.3,6292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6292,1,3,0)
 ;;=3^581.2
 ;;^UTILITY(U,$J,358.3,6292,1,4,0)
 ;;=4^NEPHROSIS MEMBRANOPROL
 ;;^UTILITY(U,$J,358.3,6292,2)
 ;;=^270345
 ;;^UTILITY(U,$J,358.3,6293,0)
 ;;=581.3^^37^446^4
 ;;^UTILITY(U,$J,358.3,6293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6293,1,3,0)
 ;;=3^581.3
 ;;^UTILITY(U,$J,358.3,6293,1,4,0)
 ;;=4^NEPHROSIS,MINIMAL CHANGE
 ;;^UTILITY(U,$J,358.3,6293,2)
 ;;=^82320
 ;;^UTILITY(U,$J,358.3,6294,0)
 ;;=581.9^^37^446^5
 ;;^UTILITY(U,$J,358.3,6294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6294,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,6294,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,6294,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,6295,0)
 ;;=446.0^^37^446^6
 ;;^UTILITY(U,$J,358.3,6295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6295,1,3,0)
 ;;=3^446.0
 ;;^UTILITY(U,$J,358.3,6295,1,4,0)
 ;;=4^POLYARTERITIS
 ;;^UTILITY(U,$J,358.3,6295,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,6296,0)
 ;;=581.81^^37^446^7
 ;;^UTILITY(U,$J,358.3,6296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6296,1,3,0)
 ;;=3^581.81
 ;;^UTILITY(U,$J,358.3,6296,1,4,0)
 ;;=4^SECONDARY NEPHROTIC SYNDROME
 ;;^UTILITY(U,$J,358.3,6296,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,6297,0)
 ;;=710.0^^37^446^8
 ;;^UTILITY(U,$J,358.3,6297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6297,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,6297,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,6297,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,6298,0)
 ;;=596.0^^37^447^1
 ;;^UTILITY(U,$J,358.3,6298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6298,1,3,0)
 ;;=3^596.0
 ;;^UTILITY(U,$J,358.3,6298,1,4,0)
 ;;=4^BLADDER NECK OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,6298,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,6299,0)
 ;;=592.0^^37^447^2
 ;;^UTILITY(U,$J,358.3,6299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6299,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,6299,1,4,0)
 ;;=4^CALCULUS OF KIDNEY
 ;;^UTILITY(U,$J,358.3,6299,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,6300,0)
 ;;=592.1^^37^447^3
 ;;^UTILITY(U,$J,358.3,6300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6300,1,3,0)
 ;;=3^592.1
 ;;^UTILITY(U,$J,358.3,6300,1,4,0)
 ;;=4^CALCULUS OF URETER
 ;;^UTILITY(U,$J,358.3,6300,2)
 ;;=^124125
 ;;^UTILITY(U,$J,358.3,6301,0)
 ;;=591.^^37^447^4
 ;;^UTILITY(U,$J,358.3,6301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6301,1,3,0)
 ;;=3^591.
 ;;^UTILITY(U,$J,358.3,6301,1,4,0)
 ;;=4^HYDRONEPHROSIS
 ;;^UTILITY(U,$J,358.3,6301,2)
 ;;=^59672
 ;;^UTILITY(U,$J,358.3,6302,0)
 ;;=344.61^^37^447^5
 ;;^UTILITY(U,$J,358.3,6302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6302,1,3,0)
 ;;=3^344.61
 ;;^UTILITY(U,$J,358.3,6302,1,4,0)
 ;;=4^NEUROGENIC BLADDER
 ;;^UTILITY(U,$J,358.3,6302,2)
 ;;=^20561
 ;;^UTILITY(U,$J,358.3,6303,0)
 ;;=753.20^^37^447^6
 ;;^UTILITY(U,$J,358.3,6303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6303,1,3,0)
 ;;=3^753.20
 ;;^UTILITY(U,$J,358.3,6303,1,4,0)
 ;;=4^UNSP OBS DEF/RENAL PEL&URET
 ;;^UTILITY(U,$J,358.3,6303,2)
 ;;=^272985
 ;;^UTILITY(U,$J,358.3,6304,0)
 ;;=599.60^^37^447^8
 ;;^UTILITY(U,$J,358.3,6304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6304,1,3,0)
 ;;=3^599.60
 ;;^UTILITY(U,$J,358.3,6304,1,4,0)
 ;;=4^URINARY OBSTRUCTION NOS
 ;;^UTILITY(U,$J,358.3,6304,2)
 ;;=^332849
 ;;^UTILITY(U,$J,358.3,6305,0)
 ;;=599.69^^37^447^7
 ;;^UTILITY(U,$J,358.3,6305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6305,1,3,0)
 ;;=3^599.69
 ;;^UTILITY(U,$J,358.3,6305,1,4,0)
 ;;=4^URINARY OBSTRUCTION NEC
 ;;^UTILITY(U,$J,358.3,6305,2)
 ;;=^332813
 ;;^UTILITY(U,$J,358.3,6306,0)
 ;;=150.9^^37^448^6
 ;;^UTILITY(U,$J,358.3,6306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6306,1,3,0)
 ;;=3^150.9
 ;;^UTILITY(U,$J,358.3,6306,1,4,0)
 ;;=4^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,6306,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,6307,0)
 ;;=154.0^^37^448^5
 ;;^UTILITY(U,$J,358.3,6307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6307,1,3,0)
 ;;=3^154.0
 ;;^UTILITY(U,$J,358.3,6307,1,4,0)
 ;;=4^COLON CANCER
 ;;^UTILITY(U,$J,358.3,6307,2)
 ;;=^267089
 ;;^UTILITY(U,$J,358.3,6308,0)
 ;;=155.0^^37^448^10
 ;;^UTILITY(U,$J,358.3,6308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6308,1,3,0)
 ;;=3^155.0
 ;;^UTILITY(U,$J,358.3,6308,1,4,0)
 ;;=4^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,6308,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,6309,0)
 ;;=157.9^^37^448^17
 ;;^UTILITY(U,$J,358.3,6309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6309,1,3,0)
 ;;=3^157.9
 ;;^UTILITY(U,$J,358.3,6309,1,4,0)
 ;;=4^PANCREATIC CANCER
 ;;^UTILITY(U,$J,358.3,6309,2)
 ;;=^267103
 ;;^UTILITY(U,$J,358.3,6310,0)
 ;;=162.9^^37^448^11
 ;;^UTILITY(U,$J,358.3,6310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6310,1,3,0)
 ;;=3^162.9
 ;;^UTILITY(U,$J,358.3,6310,1,4,0)
 ;;=4^LUNG CANCER
 ;;^UTILITY(U,$J,358.3,6310,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,6311,0)
 ;;=170.9^^37^448^2
 ;;^UTILITY(U,$J,358.3,6311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6311,1,3,0)
 ;;=3^170.9
 ;;^UTILITY(U,$J,358.3,6311,1,4,0)
 ;;=4^BONE CANCER
 ;;^UTILITY(U,$J,358.3,6311,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,6312,0)
 ;;=172.9^^37^448^14
 ;;^UTILITY(U,$J,358.3,6312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6312,1,3,0)
 ;;=3^172.9
 ;;^UTILITY(U,$J,358.3,6312,1,4,0)
 ;;=4^MELANOMA
 ;;^UTILITY(U,$J,358.3,6312,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,6313,0)
 ;;=173.81^^37^448^1
 ;;^UTILITY(U,$J,358.3,6313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6313,1,3,0)
 ;;=3^173.81
 ;;^UTILITY(U,$J,358.3,6313,1,4,0)
 ;;=4^BCCA SKIN,SITE NEC
 ;;^UTILITY(U,$J,358.3,6313,2)
 ;;=^340488
 ;;^UTILITY(U,$J,358.3,6314,0)
 ;;=173.82^^37^448^19
 ;;^UTILITY(U,$J,358.3,6314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6314,1,3,0)
 ;;=3^173.82
 ;;^UTILITY(U,$J,358.3,6314,1,4,0)
 ;;=4^SCCA SKIN,SITE NEC
 ;;^UTILITY(U,$J,358.3,6314,2)
 ;;=^340489
 ;;^UTILITY(U,$J,358.3,6315,0)
 ;;=173.89^^37^448^20
 ;;^UTILITY(U,$J,358.3,6315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6315,1,3,0)
 ;;=3^173.89
 ;;^UTILITY(U,$J,358.3,6315,1,4,0)
 ;;=4^SKIN CANCER-OTHER,SITE NEC
 ;;^UTILITY(U,$J,358.3,6315,2)
 ;;=^340490
 ;;^UTILITY(U,$J,358.3,6316,0)
 ;;=174.9^^37^448^3
 ;;^UTILITY(U,$J,358.3,6316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6316,1,3,0)
 ;;=3^174.9
 ;;^UTILITY(U,$J,358.3,6316,1,4,0)
 ;;=4^BREAST CANCER
 ;;^UTILITY(U,$J,358.3,6316,2)
 ;;=^267202
 ;;^UTILITY(U,$J,358.3,6317,0)
 ;;=180.9^^37^448^4
 ;;^UTILITY(U,$J,358.3,6317,1,0)
 ;;=^358.31IA^4^2
